Loading financials from SEC filings…
Medical care facilities · Healthcare · Fiscal year ends Dec 31
Addus HomeCare reported revenue of $1.4B in the fiscal year ended Dec 2025, up 23.2% from the year before. Operating income was $139M, an operating margin of 9.7%, and net income was $96M. Operating cash flow of $112M less capital expenditure of $8M left free cash flow of $104M.
Ranks among the 24 medical care facilities companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 864 | 951 | 1,059 | 1,155 | 1,423 |
| Cost of revenue | 595 | 651 | 719 | 780 | 961 |
| Gross profit | 270 | 300 | 340 | 375 | 462 |
| Operating income | 65.9 | 68.7 | 91.0 | 103 | 139 |
| Net interest incomeBanks | −5.5 | −8.6 | −9.6 | – | – |
| Interest expense | 5.8 | 8.9 | 11.1 | 7.7 | 13.6 |
| Pre-tax income | 60.4 | 60.2 | 81.3 | 99.4 | 127 |
| Income tax | 15.3 | 14.1 | 18.8 | 25.8 | 31.5 |
| Net income | 45.1 | 46.0 | 62.5 | 73.6 | 95.9 |
| Diluted EPS | 2.81 | 2.84 | 3.83 | 4.23 | 5.22 |
| Diluted shares | 16.1 | 16.2 | 16.3 | 17.4 | 18.4 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 169 | 80.0 | 64.8 | 98.9 | – |
| Receivables | 137 | 126 | 115 | 123 | 152 |
| Current assets | 324 | 223 | 200 | 260 | 269 |
| Net PP&E | 18.5 | 21.2 | 24.0 | 24.7 | 25.0 |
| Goodwill | 504 | 583 | 663 | 971 | 997 |
| Total assets | 948 | 938 | 1,024 | 1,413 | 1,437 |
| Payables | 19.4 | 22.1 | 26.2 | 27.2 | 16.8 |
| Deferred revenue | 0.3 | 0.9 | 0.8 | 1.7 | – |
| Current liabilities | 118 | 131 | 145 | 156 | 149 |
| Long-term debt | 221 | 132 | 124 | 218 | 121 |
| Total liabilities | 373 | 304 | 318 | 442 | 352 |
| Shareholders' equity | 574 | 634 | 707 | 970 | 1,085 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 39.5 | 105 | 112 | 116 | 112 |
| Capital expenditure | 4.6 | 8.3 | 9.5 | 6.1 | 7.7 |
| Free cash flow | 34.8 | 96.8 | 103 | 110 | 104 |
| Depreciation & amortisation | 14.5 | 14.1 | 14.1 | 13.5 | 16.4 |
| Stock-based compensation | 9.4 | 10.6 | 10.3 | 11.2 | 16.4 |
| Acquisitions | 37.4 | 98.3 | 110 | 354 | – |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 10.0% | 11.3% | 9.1% | 23.2% |
| Operating income growth (YoY) | – | 4.2% | 32.3% | 12.9% | 35.0% |
| EPS growth (YoY) | – | 1.1% | 34.9% | 10.4% | 23.4% |
| Gross margin | 31.2% | 31.5% | 32.1% | 32.5% | 32.5% |
| Operating margin | 7.6% | 7.2% | 8.6% | 8.9% | 9.7% |
| Net margin | 5.2% | 4.8% | 5.9% | 6.4% | 6.7% |
| Return on equityBlank when equity is negative | 7.9% | 7.3% | 8.8% | 7.6% | 8.8% |
| ROCEEBIT ÷ (assets − current liabilities) | 7.9% | 8.5% | 10.3% | 8.2% | 10.8% |
| Free cash flow margin | 4.0% | 10.2% | 9.7% | 9.6% | 7.3% |
| Cash conversion (CFO ÷ net income) | 0.88x | 2.28x | 1.80x | 1.58x | 1.16x |
| Receivable days | 58 | 48 | 40 | 39 | 39 |
| Payable days | 12 | 12 | 13 | 13 | 6 |
| Interest cover | 11.4x | 7.72x | 8.19x | 13.3x | 10.2x |
| Debt ÷ equity | 0.38x | 0.21x | 0.18x | 0.23x | 0.11x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | 52.0 | 51.8 | 59.3 | 120 | – |
| Current ratio | 2.76x | 1.70x | 1.38x | 1.67x | 1.80x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.